Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Lexicon Pharmaceuticals Inc: Premium Company Profile

Published by: Datamonitor

Published: Apr. 22, 2008 - 51 Pages


Table of Contents


Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Products & Services
Pipeline Products
AC Forecast Product Sales
Competitors and Strategic Business Relationships
Top Competitors
Key Suppliers
Key Clients
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
Appendix
Ask the analyst
Datamonitor consulting
Disclaimer
TABLE OF FIGURES
Figure 1: Lexicon Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
TABLE OF TABLES
Table 1: Lexicon Pharmaceuticals - Key Facts
Table 2: Lexicon Pharmaceuticals - Other Locations and Subsidiaries
Table 3: Lexicon Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 4: Lexicon Pharmaceuticals - Key Events Impacting Share Price Performance
Table 5: Lexicon Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 6: Lexicon Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 7: Lexicon Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
Table 8: Lexicon Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
Table 9: Lexicon Pharmaceuticals - In-house Pipeline Products
Table 10: Lexicon Pharmaceuticals - Collaboration Pipeline Products
Table 11: Lexicon Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
Table 12: Lexicon Pharmaceuticals - Top Competitors
Table 13: Lexicon Pharmaceuticals - Key Suppliers
Table 14: Lexicon Pharmaceuticals - Key Clients
Table 15: Lexicon Pharmaceuticals - Key Shareholders
Table 16: Lexicon Pharmaceuticals - SWOT Analysis Summary
Table 17: Lexicon Pharmaceuticals - Value Chain Analysis
Table 18: Lexicon Pharmaceuticals - Scorecard
Table 19: Lexicon Pharmaceuticals - Key Employees
Table 20: Lexicon Pharmaceuticals - Financial and Operational Overview


Abstract

Introduction

Lexicon Pharmaceuticals is a biopharmaceutical company focused on clinical development in the areas of irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. The company uses its proprietary gene knockout technology which has enabled to discover more than 100 promising drug targets and create an extensive pipeline of clinical and preclinical programs.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Lexicon Pharmaceuticals’ lead candidate is LX6171, a Phase II candidate being developed as a potential treatment for cognitive impairment associated with disorders such as Alzheimer's disease, schizophrenia and vascular dementia. Lexicon Pharmaceuticals derives its revenues from collaboration agreements associated with the company’s drug discovery alliances with Genentech, Takeda and Bristol-Myers Squibb for the research, development and commercialization of small molecule and new biotherapeutic drugs. The company’s sole contributor to total revenues out to 2010 would be license, collaboration and other revenues earned in connection with the company’s drug discovery alliances with Genentech, Takeda and Bristol-Myers Squibb for the research, development and commercialization of small molecule and new biotherapeutic drugs.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization .

Please note: This is delivered as a Zip file.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008